Skip to main content
SpringerLink
Log in

Headache

  • Chapter
Atlas of Clinical Neurology

  • 357 Accesses

Abstract

Headache is one of the most common complaints of patients seeking medical attention. There are several important indications to warrant investigation of a headache: a patient’s first or worst headache; a recent change in the patient’s headache pattern; new neurologic findings; no response to treatment; and symptoms that do not correspond to a primary headache such as migraine, tension-type, or cluster [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Couch JR: Headache to worry about. Med Clin North Am 1993, 77: 141–167.

    PubMed  CAS  Google Scholar 

  2. Rasmussen BK, Jensen R, Schroll M, Olesen J: Epidemiology of headache in a general population—a prevalence study. J Clin Epidemiol 1991, 44 (11): 1147–1157.

    Article  PubMed  CAS  Google Scholar 

  3. Lipton RB, Stewart WF: Migraine in the United States: a review of epidemiology and health care use. Neurology 1993, 43: S6 - S10.

    PubMed  CAS  Google Scholar 

  4. Schwartz BS, Stewart WF, Simon D, Lipton RB: Epidemiology of tension-type headache. JAMA 1998, 279 (5): 381–383.

    Article  PubMed  CAS  Google Scholar 

  5. Headache Classification Committee of the International Headache Society: Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988, 7: 1–96.

    Google Scholar 

  6. Launer LJ, Terwindt GM, Ferrari MD: The prevalence and characteristics of migraine in a population-based cohort: the GEM study. Neurology 1999, 53 (3): 537–542.

    Article  PubMed  CAS  Google Scholar 

  7. Stewart WF, Linet MS, Celentano DD, et al.: Age-and sex-specific incidence rates of migraine with and without aura. Am J Epidemiol 1991, 134:1111–1120.

    Google Scholar 

  8. S. Stewart WF, Lipton RB, Liberman J: Variation in migraine prevalence by race. Neurology 1996, 47 (1): 52–59.

    Article  PubMed  CAS  Google Scholar 

  9. Lipton RB, Stewart WF: Acute migraine therapy. Headache 1999, 39: S20 - S26.

    Article  Google Scholar 

  10. Hu XH, Markson LE, Lipton RB, et al.: Burden of migraine in the United States: disability and economic costs. Arch Intern Med 1999, 159(8):813–818.

    Google Scholar 

  11. Terwindt GM, Ferrari MD, Tijhuis M, et al.: The impact of migraine on quality of life in the general population: the GEM study. Neurology 2000, 55:624–629.

    Google Scholar 

  12. Couch JR: Complexities of presentation and pathogenesis of migraine headache. In Treating the Headache Patient. Edited by Cady RK, Fox AW. New York: Marcel Dekker; 1995.

    Google Scholar 

  13. Lenaerts M: Migraine and epilepsy: comorbidity and temporal relationship. Paper presented at: Ninth Congress of the International Society; June 1999; Barcelona, Spain.

    Google Scholar 

  14. Merikangas KR, Merikangas JR, Angst J: Headache syndromes and psychiatric disorders: association and familial transmission. J Psychiatr Res 1993, 27: 197–210.

    Article  PubMed  CAS  Google Scholar 

  15. Olesen J, Tfelt-Hansen P, Welch KMA: The Headaches. New York: Raven Press; 1993: 256–266.

    Google Scholar 

  16. Lennox WG, Gibbs EL, Gibbs FA: Effect of ergotamine tartrate on the cerebral circulation of man. J Pharmacol Exp Ther 1935, 53: 113.

    CAS  Google Scholar 

  17. Ledo AAP: Spreading depression of activity in cerebral cortex. J Neurophysiol 1944, 7: 359–390.

    Google Scholar 

  18. Lashley KS: Patterns of cerebral integration indicated by scotomas of migraine. Arch Neurol Psychiat 1941, 46: 331.

    Article  Google Scholar 

  19. Lauritzen M, Olesen J: Regional cerebral blood flow during migraine attacks by Xenon-133 inhalation and emission tomography. Brain 1984, 107: 447–461.

    Article  PubMed  Google Scholar 

  20. Olesen J, Friberg L, Olsen TS, et al.: Timing and topography of cerebral blood flow, aura, and headache during migraine attacks. Ann Neurol 1990, 28:791–798.

    Google Scholar 

  21. Cutrer FM, Sorensen AG, Weisskoff RM, et al.: Perfusion-weighted imaging defects during spontaneous migrainous aura. Ann Neurol 1998, 43:25–31.

    Google Scholar 

  22. Woods RP, Iacoboni M, Mazziotta JC: Brief report: bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med 1994, 331: 1689–1692.

    Article  PubMed  CAS  Google Scholar 

  23. Weiner C, May A, Limmroth V, et al.: Brain stem activation in spontaneous human migraine attacks. Nat Med 1995, 1:658–660.

    Google Scholar 

  24. Raskin NH, Hosobuchi Y, Lamb S: Headache may arise from perturbation of brain. Headache 1987, 27: 416–420.

    Article  PubMed  CAS  Google Scholar 

  25. Goadsby PJ, Edvinsson L, Ekman R: Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 1990, 28: 183–187.

    Article  PubMed  CAS  Google Scholar 

  26. Moskowitz MA: Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol Sci 1992, 13: 307–311.

    Article  PubMed  CAS  Google Scholar 

  27. Goadsby PJ, Zagami AS, Lambert GA: Neural processing of craniovascular pain: a synthesis of the central-structures involved in migraine. Headache 1991, 31: 365–371.

    Article  PubMed  CAS  Google Scholar 

  28. Schoenen REF: Contingent negative variation: methods and potential interest in headache. Cephalalgia 1993, 13 (1): 28–32.

    Article  PubMed  CAS  Google Scholar 

  29. tlfra J, Cecchini AP, DePasqua V, et al.: Visual evoked potentials during long periods of pattern-reversal stimulation in migraine. Brain 1998, 121:233–241.

    Google Scholar 

  30. Wang W, Lenaerts M, Schoenen J: Reduced habituation of pattern-reversal visual evoked responses in migraine. Paper presented at: International Conference of the European Headache Federation; June 1994; Liege, Belgium.

    Google Scholar 

  31. Welch KMA, Cao Y, Aurora S, et al.: MRI of the occipital cortex, red nucleus, and substantia nigra during visual aura of migraine. Neurology 1998, 51:1465–1469.

    Google Scholar 

  32. Joutel A, Bousser MG, Biousse V, et al.: A gene for familial hemiplegic migraine maps to chromosome 19. Nat Genet 1993, 5:40–45.

    Google Scholar 

  33. Ophoff RA, Terwindt GM, Vergouwe MN, et al.: Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Ce11 1996, 87:543–552.

    Google Scholar 

  34. Barbiroli B Montagna P, Cortelli P, et al.: Abnormal brain and muscle metabolism shown by 31P magnetic resonance spectroscopy in patients affected by migraine with aura. Neurology 1992, 42:1209–1214.

    Google Scholar 

  35. Welch KM, Levine SR, D’Andrea G, et al.: Preliminary observation on brain energy metabolism in migraine studied by in vivo phosphorus 31 NMR spectroscopy. Neurology 1989, 39:538–541.

    Google Scholar 

  36. Ferrari MD, Odink J, Tapparelli C, et al.: Serotonin metabolism in migraine. Neurology 1989, 39:1239–1242.

    Google Scholar 

  37. Humphrey PPA: 5-Hydroxytryptamine and the pathophysiology of migraine. J Neurol 1991, 238:S38–S44.

    Google Scholar 

  38. Ferrari MD: Systemic biochemistry. In The Headaches. Edited by Olesen J, Tfelt-Hansen P, Welch KMA. New York: Raven Press; 1993: 179–183.

    Google Scholar 

  39. Parsons AA, Whalley ET: Characterization of the 5-HT receptor which mediates contraction of the human isolated basilar artery. Cephalalgia 1989, 9 (S9): 47–51.

    PubMed  Google Scholar 

  40. Fozard JR, Kalkman HO: 5-HT in nervous system disease and migraine. Curr Opin Neural Neurosurg 1992, 5 (4): 496–502.

    CAS  Google Scholar 

  41. Peroutka SJ: Antimigraine drug interactions with serotonin receptor subtypes in human brain. Ann Neural 1988, 23 (5): 500–504.

    Article  CAS  Google Scholar 

  42. Peroutka SJ: Dopamine and migraine. Neurology 1997, 49 (3): 650–656.

    Article  PubMed  CAS  Google Scholar 

  43. Goadsby PJ: The pathophysiology of primary headache. In Headache in Clinical Practice. Edited by Silberstein SD, Lipton RB, Goadsby PJ. Oxford: ISIS Medical Media; 1998.

    Google Scholar 

  44. Storer RJ, Goadsby PJ: Trigeminovascular nociceptive transmission involves N-methyl-D-aspartate and non-N-methyl-D-aspartate glutamate receptors. Neuroscience 1999, 90 (4): 1371–1376.

    Article  PubMed  CAS  Google Scholar 

  45. Schoenen J, Sianard-Gainko J, Lenaerts M: Blood magnesium levels in migraine. Cephalalgia 1991, 11: 97–99.

    Article  PubMed  CAS  Google Scholar 

  46. Ramadan NM, Halvorson H, Vande-Linde A, et al. Low brain magnesium level in migraine. Headache 1989, 29 (7): 416–419.

    Article  PubMed  CAS  Google Scholar 

  47. Somerville BM: The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology 1972, 22: 355–365.

    Article  PubMed  CAS  Google Scholar 

  48. Welch KMA, Darnley D, Simkins RT: The role of estrogens in migraine: a review and hypothesis. Cephalalgia 1984, 4: 227–236.

    Article  PubMed  CAS  Google Scholar 

  49. Mathew NT, Kailasam J, Meadors L, et al.: Intravenous valproate sodium (depacon) aborts migraine rapidly: a preliminary report. Headache 2000, 40(9):720–723.

    Google Scholar 

  50. Goadsby PJ, Hargreaves RJ: Mechanisms of action of serotonin 5-HT1B/D agonists: insights into migraine pathophysiology using rizatriptan. Neurology 2000, 55: S8 - S14.

    PubMed  CAS  Google Scholar 

  51. Goadsby PJ: The scientific basis of medication choice in symptomatic migraine treatment. Can J Neurol Sci 1999, 26: 20–26.

    Google Scholar 

  52. Humphrey PP, Feniuk W: Mode of action of the anti-migraine drug sumatriptan. Trends Pharmacol Sci 1991, 12: 444–446.

    Article  PubMed  CAS  Google Scholar 

  53. Silberstein SD: Rizatriptan versus usual care in long-term treatment of migraine. Neurology 2000, 55: S25 - S28.

    Article  PubMed  CAS  Google Scholar 

  54. Solomon GD, Cady RK, Klapper JA, et al.: Clinical efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraine. Neurology 1997, 49:1219–1225.

    Google Scholar 

  55. Nappi G, Sicuteri F, Byrne M, et al.: Oral sumatriptan compared with placebo in the acute treatment of migraine. J Neurol 1994, 241:138–144.

    Google Scholar 

  56. Sargent J, Kirchner J, Davis R, Kirkhart B: Oral sumatriptan is effective and well tolerated for the acute treatment of migraine: results of a multicenter study. Neurology 1995, 45: S10 - S14.

    PubMed  CAS  Google Scholar 

  57. Tfelt-Hansen P, Ryan RE Jr: Oral therapy for migraine: comparisons between rizatriptan and sumatriptan. A review of four randomized, double-blind clinical trials. Neurology 2000, 55: S19 - S24.

    PubMed  CAS  Google Scholar 

  58. The International 311C90 Long-term Study Group: The long-term tolerability and efficacy of oral zolmitriptan (Zomig, 311C90) in the acute treatment of migraine. An international study. Headache 1998, 38: 173–183.

    Google Scholar 

  59. Cady RK, Lipton RB, Hall C, et al.: Treatment of mild headache in disabled migraine sufferers: results of the Spectrum Study. Headache 2000, 40(10):792–797.

    Google Scholar 

  60. Lipton RB, Stewart WF, Cady R, et al.: Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study. Headache 2000, 40(10):1–9.

    Google Scholar 

  61. Raskin NH: Repetitive intravenous dihydroergotamine as therapy for intractable migraine. Neurology 1986, 36 (7): 995–997.

    Article  PubMed  CAS  Google Scholar 

  62. Goadsby PJ: How do the currently used prophylactic agents work in migraine? Cephalalgia 1997, 17: 85–92.

    Article  PubMed  CAS  Google Scholar 

  63. Breslau N, Merikangas K, Bowden CL: Comorbidity of migraine and major affective disorders. Neurology 1994, 44: S17 - S22.

    PubMed  CAS  Google Scholar 

  64. Breslau N, Davis GC, Schultz LR, Peterson EL: Migraine and major depression: a longitudinal study. Headache 1994, 34: 387–393.

    Article  PubMed  CAS  Google Scholar 

  65. Schoenen J, Jacquy J, Lenaerts M: Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology 1998, 50: 466–470.

    Article  PubMed  CAS  Google Scholar 

  66. Silberstein SD, Silberstein MM: New concepts in the pathogenesis of headache: migraine versus tension-type headache. Phys Assist 1991, 9: 67–81.

    Google Scholar 

  67. Jensen R, Olesen J: Initiating mechanisms of experimentally-induced tension-type headache. Cephalalgia 1996, 16: 175.

    Article  PubMed  CAS  Google Scholar 

  68. Schoenen J, Sandor P: Headache. In Textbook of Pain, edn 4. Edited by Wall PD, Melzack R. New York: Churchill Livingstone; 1999.

    Google Scholar 

  69. Lance JW, Ekbom K: In Cluster Headaches: Mechanism and Management. Edited by Kudrow L. New York: Oxford University Press; 1980: 27–28.

    Google Scholar 

  70. Hardebo JE: On pain mechanisms in cluster headache. Headache 1991, 31: 91–106.

    Article  PubMed  CAS  Google Scholar 

  71. May A, Bahra A, Büchel, et al.: PET and MRA findings in cluster headache and MRA in experimental pain. Neurology 2000, 55:1328–1335.

    Google Scholar 

  72. Lenaerts M, Couch JR: Trigeminal neuralgia. Emedicine [serial online]. 2001. Available at: http://www.emedicine.com/oph/NEUROLOGIC_DISORDERS.htm. Accessed January 25, 2001.

    Google Scholar 

  73. Blom S: Trigeminal neuralgia: a treatment with a new anticonvulsant drug. Lancet 1962, 1: 839–840.

    Article  PubMed  CAS  Google Scholar 

  74. Fromm GH, Terrence CF, Chattha AS: Baclofen in the treatment of trigeminal neuralgia: double-blind study and long-term follow-up. Ann Neurol 1984, 15 (3): 240–244.

    Article  PubMed  CAS  Google Scholar 

  75. McLaughlin MR, Jannetta PJ, Clyde BL, et al.: Microvascular decompression of cranial nerves: lessons learned after 4400 operations. J Neurosurg 1999, 90(1):1–8.

    Google Scholar 

  76. Evans RW, Armon C, Frohman EM, Goodin DS: Assessment: prevention of post-lumbar puncture headaches: report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology. Neurology 2000, 55: 909–914.

    Article  PubMed  CAS  Google Scholar 

  77. Lenaerts M, Pepin JL, Tombu S, Schoenen J: No significant effect of an “atraumatic” needle on the incidence of post-lumbar puncture headache or traumatic tap. Cephalalgia 1993, 13: 296–297.

    Article  PubMed  CAS  Google Scholar 

  78. Williams E, Fawcett W, Jenkins G: Preventing headache after lumbar puncture. Optimism generally quoted for epidural blood patching is unwarranted. BMJ 1998, 317: 1588–1589.

    PubMed  CAS  Google Scholar 

  79. Panagopoulos G, Gotsi A, Piaditis G, et al.: Treatment of benign intracranial hypertension with octreotide [abstract]. American Academy of Neurology. 1998.

    Google Scholar 

  80. Lou L: Uncommon areas of electrical stimulation for pain relief. Curr Rev Pain 2000, 4 (5): 407–412.

    Article  PubMed  CAS  Google Scholar 

  81. Weiner RL: The future of peripheral nerve neurostimulation. Neurol Res 2000, 22: 299–303.

    PubMed  CAS  Google Scholar 

  82. Sjaastad O, Saunte C, Hovdahl H, et al.: “Cervicogenic” headache: a hypothesis. Cephalalgia 1983, 3(4):249–256

    Google Scholar 

  83. Sjaastad O, Fredriksen TA, Pfaffenrath V: Cervicogenic headache: diagnostic criteria. Headache 1990, 30: 725–726.

    Article  PubMed  CAS  Google Scholar 

  84. Dalessio JD: In Wolfs Headache and Other Head Pain, edn 3. Edited by Dalessio JD, Silberstein SD. New York: Oxford University Press; 1972: 71.

    Google Scholar 

  85. Tournier-Lasserve E, Joutel A, Melki J, et al.: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19g12. Nat Genet 1993, 3:256–259.

    Google Scholar 

  86. Day JW, Raskin NH: Thunderclap headache: symptom of unruptured cerebral aneurysm. Lancet 1986, 2: 1247–1248.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Marc E. Lenaerts
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James R. Couch Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The University of Texas Southwestern Medical Center, Dallas, Texas, USA

    Roger N. Rosenberg MD (Professor of Neurology and Physiology, Zale Distinguished Chair in Neurology, Senior Neurologist) (Professor of Neurology and Physiology, Zale Distinguished Chair in Neurology, Senior Neurologist)

  2. Zale-Lipshy University Hospital and Parkland Memorial Hospital, Dallas, Texas, USA

    Roger N. Rosenberg MD (Professor of Neurology and Physiology, Zale Distinguished Chair in Neurology, Senior Neurologist) (Professor of Neurology and Physiology, Zale Distinguished Chair in Neurology, Senior Neurologist)

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Lenaerts, M.E., Couch, J.R. (2003). Headache. In: Rosenberg, R.N. (eds) Atlas of Clinical Neurology. Current Medicine Group, London. https://doi.org/10.1007/978-1-4757-4552-8_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-4552-8_15

  • Publisher Name: Current Medicine Group, London

  • Print ISBN: 978-1-4757-4554-2

  • Online ISBN: 978-1-4757-4552-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation